• 1
    Nicolson Gl. Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 1988; 7: 143188.
  • 2
    Hynes Ro, Lander Ad. Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons. Cell 1992; 68: 303322.
  • 3
    Nakamura T., Nawa K., Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Com-mun 1984; 122: 14501459.
  • 4
    Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., Tashiro K., Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440443.
  • 5
    Matsumoto K., Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncogenesis 1992; 3: 2754.
  • 6
    Bottaro Dp, Rubin Js, Faletto Dl, Chan Aml, Kmiecik Te, Vande Woude Gf, Aaronson Sa. Identification of the hepatocyte growth factor receptor as the c-metproto-oncogene product. Science 1991; 251: 802804.
  • 7
    Gherardi E., Stoker M. Hepatocyte growth factor-scatter factor: mitogen, motogen, and met. Cancer Cells 1991; 3: 227232.
  • 8
    Chung Lwk, Li W., Gleave Me, Hsieh Jt, Wu Hc, Sikes Ra, Zhau He, Bandyk Mg, Logothetis Cj, Rubin Js, Voneschenbach Ac. Human prostate cancer model: roles of growth factors and extracellular matrices. J Cell Biochem 1992; 16H(suppl): 99105.
  • 9
    Matsumoto K., Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem 1996; 119: 591600.
  • 10
    Kasai S., Sugimura K., Matsumoto K., Nishi N., Kishimoto T., Nakamura T. Hepatocyte growth factor is a paracrine regulator of rat prostate epithelial growth. Biochem Biophys Res Commun 1996; 228: 646652.
  • 11
    Humphrey Pa, Zhu X., Zarnegar R., Swanson Pe, Ratliff Tl, Vollmer Rt, Day Ml. Hepatocyte growth factor and its receptor (c-met) in prostatic carcinoma. Am J Pathol 1995; 147: 386396.
  • 12
    Horoszewicz Js, Leong Ss, Kawinski E., Karr Jp, Rosenthal H., Chu Tm, Mirand Ea, Murphy Gp. LNCaP model of human prostatic carcinoma. Cancer Res 1983; 43: 18091818.
  • 13
    Kaighn Me, Narayan Ks, Ohnuki Y., Lechner Jf, Jones Lw. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979; 17: 1623.
  • 14
    Stone Kr, Mickey Dd, Wunderli H., Mickey Gh, Paulson Df. Isolation of a human prostate carcinoma cell line (DU145). Int J Cancer 1978; 21: 274281.
  • 15
    Repesh La. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 1989; 9: 192208.
  • 16
    Matsumoto K., Date K., Shimura H., Nakamura T. Acquisition of invasive phenotype in gallbladder in cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor. Jpn J Cancer Res 1996; 87: 702710.
  • 17
    Fu X., Herrera H., Hoffman Rm. Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue. Int J Cancer 1992; 52: 987990.
  • 18
    Stephenson Ra, Dinney Cpn, Gohji K., Ordonez Ng, Killion Jj, Fidler Ij. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 1992; 84: 951957.
  • 19
    Pisters Ll, Troncoso P., Zhau He, Li W., von Eschenbach Ac, Chung Lwk. c-met proto-oncogene expression in benign and malignant human prostate tissues. J Urol 1995; 154: 293298.
  • 20
    Matsumoto K., Nakamura T. Pleiotropic roles of HGF in mitogenesis, morphogenesis, and organ regeneration. Gann Monograph on Cancer Res 1994; 42: 91112.